TNF and rheumatoid arthritis: Given that TNF blockade has proved a highly effective therapy for RA [62],[63] and response to TNF-antagonists among RA patients is known to vary, investigation of whether the TRAF1 variants identified in this study play a role in this differential response may be a fruitful pharmacogenetic avenue to pursue.